Resultaten voor 'oliver gassmann'

4 resultaten
  1. Führung und Organisation pharmazeutischer Innovation
    1. Oliver Gassmann
    2. Alexander Schuhmacher
    3. Max von Zedtwitz

    Führung und Organisation pharmazeutischer Innovation

    Wie man den Wettlauf der Life Sciences gewinnt

    Dieses Buch untersucht und beleuchtet die wichtigsten Herausforderungen, denen sich die pharmazeutische Industrie in einem zunehmend wettbewerbsorientierten Umfeld mit inflationären F&E-Investitionen und verschärftem Kostendruck stellen muss.

    € 49,50
  2. Leading Pharmaceutical Innovation
    1. Oliver Gassmann
    2. Alexander Schuhmacher
    3. Max von Zedtwitz

    Leading Pharmaceutical Innovation

    How to Win the Life Science Race

    This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D; investments and tightening cost control pressures.

    € 71,50
  3. Leading Pharmaceutical Innovation
    1. Oliver Gassmann
    2. Gerrit Reepmeyer
    3. Maximilian von Zedtwitz

    Leading Pharmaceutical Innovation

    Trends and Drivers for Growth in the Pharmaceutical Industry

    We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D.

    € 62,50
  4. Leading Pharmaceutical Innovation
    1. Oliver , Gassmann
    2. Alexander , Schuhmacher
    3. Max Von , Zedtwitz

    Leading Pharmaceutical Innovation

    This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D; investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D.; New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation.

    € 85,59